Filing Details
Vaxart, Inc. (OTC:VXRT) filed a Form 8-K with the Securities and Exchange Commission on July 28, 2026, disclosing a material event.
8k filedOTC:VXRT
Vaxart, Inc. (VXRT) Reports Material Event to SEC
Filing Details Vaxart, Inc. (OTC:VXRT) filed a Form 8-K with the Securities and Exchange Commission on July 28, 2026, disclosing a material event. Market Context Vaxart, Inc.'s…
Market Context
Vaxart, Inc.'s stock currently trades at $0.48 with a market capitalization of $87.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Vaxart, Inc.'s stock.
All SEC filings for Vaxart, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VXRT Stock Page
Frequently Asked Questions
Where can I read VXRT's SEC filings?
Browse all filings on our VXRT SEC filings page.
What types of SEC filings does Vaxart, Inc. file?
Public companies like Vaxart, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.